Last checked at 14 Jan 2021 07:00
14 January 2021
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
Accrol Group Holdings plc
(the "Company")
AIM: ACRL
PDMR Dealings
Accrol Group Holdings plc, a leading independent tissue converter in the UK, announces that as a result of the Company releasing its half-year results for the six months ended 31 October 2020, certain shares held by PDMRs have ceased to be locked in and as a result the following PDMR dealings have occurred.
PDMR | Number of ordinary shares held pre dealing | Number of ordinary shares sold | Number of ordinary shares held post dealing | % of issued share capital held post dealing |
Gareth Jenkins | 5,598,632 | 1,333,000 | 4,265,632 | 1.37% |
Mark Dewhurst | 1,489,975 | 444,000 | 1,045,975 | 0.34% |
Graham Cox | 683,970 | 333,000 | 350,970 | 0.11% |
Further details of the PDMR dealings are included below.
For further information, please contact: | |
Accrol Group Holdings plc | |
Dan Wright, Executive Chairman | Via Belvedere Communications |
Gareth Jenkins, Chief Executive Officer | |
Zeus Capital Limited (Nominated Adviser & Broker) | |
Dan Bate / Jordan Warburton | Tel: +44 (0) 161 831 1512 |
Dominic King / John Goold | Tel: +44 (0) 203 829 5000 |
Liberum Capital Limited (Joint Broker) | Tel: +44 (0) 20 3100 2222 |
Clayton Bush / Edward Thomas | |
Belvedere Communications Limited | |
Cat Valentine | Tel: +44 (0) 7715 769 078 |
Keeley Clarke | Tel: +44 (0) 7967 816 525 |
Llew Angus | Tel: +44 (0) 7407 023 147 |
accrolpr@belvederepr.com |
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisition of a state-of-the-art tissue converter based in Leicester, the Group now operates from five sites, including four in Lancashire, which generate revenues totalling c.16% of the £1.7bn UK retail tissue market.
For more information, please visit www.accrol.com.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Gareth Jenkins |
2 | Reason for the notification | |
a) | Position/status | Chief Executive Officer |
b)
| Initial notification /Amendment | Initial notification |
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Accrol Group Holdings plc |
b) | LEI | 213800MC56M5G69RJ226 |
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a)
| Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.001 each
ISIN: GB00BZ6VT592 |
b) | Nature of the transaction | Sale of shares |
c) | Price(s) and volume(s) | Price: £0.705 Volume: 1,333,000 |
d) | Aggregated information - Aggregated volume - Price | Price: £0.705 Volume: 1,333,000 |
e) | Date of the transaction | 13 January 2021 |
f) | Place of the transaction | London Stock Exchange, AIM |
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Mark Dewhurst |
2 | Reason for the notification | |
a) | Position/status | Chief Operating Officer |
b)
| Initial notification /Amendment | Initial notification |
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Accrol Group Holdings plc |
b) | LEI | 213800MC56M5G69RJ226 |
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a)
| Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.001 each
ISIN: GB00BZ6VT592 |
b) | Nature of the transaction | Sale of shares |
c) | Price(s) and volume(s) | Price: £0.705 Volume: 444,000 |
d) | Aggregated information - Aggregated volume - Price | Price: £0.705 Volume: 444,000 |
e) | Date of the transaction | 13 January 2021 |
f) | Place of the transaction | London Stock Exchange, AIM |
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Graham Cox |
2 | Reason for the notification | |
a) | Position/status | Commercial Director |
b)
| Initial notification /Amendment | Initial notification |
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Accrol Group Holdings plc |
b) | LEI | 213800MC56M5G69RJ226 |
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a)
| Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.001 each
ISIN: GB00BZ6VT592 |
b) | Nature of the transaction | Sale of shares |
c) | Price(s) and volume(s) | Price: £0.705 Volume: 333,000 |
d) | Aggregated information - Aggregated volume - Price | Price: £0.705 Volume: 333,000 |
e) | Date of the transaction | 13 January 2021 |
f) | Place of the transaction | London Stock Exchange, AIM |